Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4465961 | 4213445 | F | 1 | 4465961-3 | 20040604 | 20040916 | 20040930 | EXP | 2004231579FR | PFIZER INC. | 35 | YR | M | N | 20040927 | MD |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4465961 | 1005264989 | PS | DOXORUBICIN HCL | 1 | INTRAVENOUS | 50 MG (25 MG/M2), CYCLIC, IV | D | D | 50467 | ||
| 4465961 | 1005287322 | SS | BLEOMYCIN SULFATE | 1 | INTRAVENOUS | 20 MG (10 MG/M2), CYCLIC, IV | D | D | |||
| 4465961 | 1005287327 | SS | DETICENE (DACARBAZIDE) | 2 | INTRAVENOUS | 800 MG (375 MG/M2), CYCLIC, IV | D | D | |||
| 4465961 | 1005287328 | SS | VELBAN | 1 | INTRAVENOUS | 12 MG (6 MG/M2), CYCLIC, IV | D | D |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4465961 | 1005264989 | HODGKIN'S DISEASE NODULAR SCLEROSIS STAGE UNSPECIFIED |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4465961 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4465961 | HYPERTHERMIA |
| 4465961 | IATROGENIC INJURY |
| 4465961 | INTERSTITIAL LUNG DISEASE |
| 4465961 | RESPIRATORY DISTRESS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4465961 | FGN |
| 4465961 | HP |
| 4465961 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4465961 | 1005264989 | 20040521 | 20040604 | ||
| 4465961 | 1005287322 | 20040521 | 20040604 | ||
| 4465961 | 1005287327 | 20040521 | 20040604 | ||
| 4465961 | 1005287328 | 20040521 | 20040604 |